EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.11.1 | Acute Coronary Syndrome |
22329616 |
Cilostazol and Primary-PCI: Mirage or Good Alternative? |
causal interaction therapeutic application unassigned |
2 4 0 |
3.1.11.1 | Acute Kidney Injury |
1352809 |
Further characterization of the protective effect of 8-cyclopentyl-1,3-dipropylxanthine on glycerol-induced acute renal failure in the rat. |
therapeutic application unassigned |
1 0 |
3.1.11.1 | Acute Kidney Injury |
7643525 |
Zaprinast accelerates recovery from established acute renal failure in the rat. |
therapeutic application unassigned |
4 0 |
3.1.11.1 | Acute Kidney Injury |
8764333 |
Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. |
causal interaction therapeutic application unassigned |
2 4 0 |
3.1.11.1 | Acute Kidney Injury |
8968341 |
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine. |
causal interaction therapeutic application unassigned |
3 4 0 |
3.1.11.1 | Acute Kidney Injury |
11022970 |
Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivo. |
causal interaction therapeutic application unassigned |
4 2 0 |
3.1.11.1 | Acute Kidney Injury |
12235272 |
Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. |
causal interaction ongoing research therapeutic application unassigned |
2 4 2 0 |
3.1.11.1 | Acute Kidney Injury |
17430259 |
Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure. |
causal interaction ongoing research therapeutic application unassigned |
1 3 4 0 |
3.1.11.1 | Acute Kidney Injury |
33865881 |
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats. |
diagnostic usage ongoing research therapeutic application unassigned |
2 3 4 0 |
3.1.11.1 | Acute Lung Injury |
9299282 |
Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury. |
causal interaction therapeutic application unassigned |
4 2 0 |